Newborn Screening for Deafness/Hard of Hearing in the Genomic Era.

Clinical chemistry
Authors
Abstract

BACKGROUND: Newborn hearing screening is a physiologic screen to identify infants who may be deaf or hard of hearing (DHH) and would benefit from early intervention. Typically, an infant who does not pass the newborn hearing screen is referred for clinical audiology testing, which may be followed by genetic testing to identify the etiology of an infant's DHH.CONTENT: The current newborn hearing screening paradigm can miss mild cases of DHH or later-onset DHH, leaving a child at risk for unrecognized DHH, which could impact long-term language, communication, and social development. Genomic technologies are improving the diagnosis of DHH in newborns who fail their newborn hearing screen, and a case is being made for genomic screening for DHH in all newborns.SUMMARY: The genomic era brings a wealth of opportunities to screen newborns for genetic causes of hearing loss on a population wide basis, some of which are already being implemented in a clinical setting.

Year of Publication
2025
Journal
Clinical chemistry
Volume
71
Issue
1
Pages
54-60
Date Published
01/2025
ISSN
1530-8561
DOI
10.1093/clinchem/hvae193
PubMed ID
39749514
Links